National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy.
An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.
Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected.
A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.